ARTICULOS ORIGINALES

Introducción de un ELISA como ensayo alternativo en la determinación de la potencia de vacunas antitetánicas.

Introduction of an ELISA as an alternative assay for potency testing of tetanus toxoid vaccines.

Juan Carlos Ramírez, Esther María Fajardo, Beatriz Romeu, Ubel Jesús Ramírez, Eduardo Álvarez, Rolando Ochoa, Alicia Perojo, Regla Sosa, Deolinda Silva, Irma Labrador, Adina García, Pablo González, Luis Izquierdo.

Instituto Finlay. Centro de Investigación-Producción de Vacunas y Sueros. Ciudad de La Habana, Cuba. E-mail: [e-mail]

---

RESUMEN

Por más de medio siglo de uso, la vacunación con el toxoide tetánico ha mostrado un elevado porcentaje de eficacia en la prevención del tétanos. Este trabajo pretende introducir un ensayo inmunoenzimático en fase sólida (ELISA) como método alternativo a la prueba de seroneutralización in vivo utilizada en la evaluación de la potencia de las vacunas antitetánicas.Se desarrolló un ELISA de tipo indirecto para la cuantificación de antitoxina tetánica en suero de curiel a partir de un estándar con 29 UI/mL, previamente calibrado. Se determinó la precisión, exactitud y linealidad del ensayo. Se analizó la correlación entre el ELISA y la prueba biológica mediante la evaluación de un total de 75 muestras de sueros por ambos métodos. Por último, se estudió la respuesta individual de un grupo de animales contra 15 lotes de toxoide tetánico. El ensayo demostró ser preciso y exacto, con imprecisiones inferiores al 20% y valores de recuperación entre el 90–110%. Las desviaciones del paralelismo mostraron coeficientes de variación alrededor del 10%. El análisis por regresión lineal mostró una buena correlación entre el ELISA y el ensayo biológico (R2= 0,989). El método alternativo desarrollado probó ser una herramienta útil para la determinación de la potencia de vacunas antitetánicas a partir de la evaluación independiente de la respuesta de cada animal contra el toxoide tetánico.Los niveles de seroprotección alcanzados se encontraron entre el 83–100%.

Palabras claves: ELISA, métodos alternativos, ensayos in vitro, toxoide tetánico.

---

ABSTRACT

An indirect enzyme-linked immunosorbent assay (ELISA) was developed to quantify tetanus antitoxin activity in guinea pig sera based on a previously calibrated standard. This test is proposed as an alternative to the traditional in vivo neutralization assay used for potency evaluation of tetanus vaccines.The accuracy, precision and linearity of our ELISA were determined. Both methods were used to evaluate 75 guinea pig sera and the results were compared by linear regression analysis. The individual immunological responses against different lots of tetanus vaccine were also studied. The ELISA showed an excellent accuracy, with recovery values between 90-110%; intra, inter and total-assay imprecision ranging around 10% and parallelism deviations below 10%. A high correlation was found between our ELISA and the in vivo neutralization assay (R2= 0,989). The seroprotection levels of the tetanus vaccines tested were over 83%. All those results indicate our ELISA is an excellent alternative procedure for potency testing of tetanus toxoid vaccines.

Keywords: ELISA, alternative methods, in vitro tests, tetanus toxoid

---

Texto completo formato PDF

REFERENCIAS

1.Halder M. Three Rs Potential in the development and quality control of immunobiologicals. AlTEEK. 2001; 18 suppl 1:13-46.
2. Hartung T. Three Rs Potential in the development and quality control of pharmaceuticals. AlTEEK. 2001; 18 suppl 1:1-12.
3. Winsnes R, et al. Serological assays as alternatives to the challenge test for batch release of tetanus vaccines for human use. Dev Biol Stand. 1999; 101:277-288.
4. Hong HA, et al. The use of alternatives to animal test in developing countries. Dev Biol Stand. 1999; 101:209-214.
5. Hill EH. In vitro alternatives to animal testing: breakthroughs and challenges. Animal Guardian. 1999; 14-16.
6. Milstien J. WHO activities towards the three Rs in the development and control of biological products. Dev Biol Stand. 1996; 86:31-39.
7. Halder M., et al. ECVAM’s contribution to the implementation of the Three Rs in the production and quality control of biologicals. ATLA. 2002; 30:93-108.
8. Zaffran M. Immunize every child: GAVI strategy for sustainable immunization services. GAVI Second Board Meeting. 2000; 9-44.
9. Peel MM. Measurement of tetanus antitoxin: II, toxin neutralization. J Biol Stand. 1980; 8: 191-207.
10. Peel MM. Measurement of tetanus antitoxin: I, indirect haemagglutination. J Biol Stand. 1980; 8:177-189.
11. Gupta RK, Maheshwari SC, Singh H. The titration of tetanus antitoxin: II, a comparative evaluation of the indirect haemagglutination and toxin neutralization tests. J Biol Stand. 1984; 12:137-143.
12. Maheshwari SC. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination. J Commun Dis. 1998; 30(1):23-28.
13. Gentili G, Pini C, Collotti C. The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination. J Biol Stand. 1985; 13:53-59.
14. Hendriksen CFM, et al. Interlaboratory validation of in vitro serological assay systems to asses the Potency of Tetanus Toxoid in Vaccines for Veterinary Use. Biologicals. 1994; 22:257-268.
15. Gupta RK, Siber GR. Use of in Vitro Cell Assay and ELISA in the United States Potency Test of vaccines containing Adsorbed Diphtheria and Tetanus Toxoids. Dev Biol Stand. 1996; 86:207-215.
16. Ochoa R, et al. Validación de un ELISA para la cuantificación de antitoxina tetánica en suero humano. Vaccimonitor. 2000; 9(4):16-21.
17. Van der Gun J, et al. Validation of the toxinbinding inhibition (ToBI) test for estimation of the potency of the tetanus toxoid component in vaccines. Dev Biol Stand. 1996; 86:199-206.
18. Habermann E, Wiegand H. A rapid and simple radio immunological procedure for measuring low concentrations of tetanus antibodies. Naunyn Schmiedebergs Arch. Pharmacol. 1973; 276:321-326.
19.Aggerbeck H, Norgaand-Pedersen B, Heron I. Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, timeresolved fluorescence immunoassay. J Immunological Methods. 1996; 190:171-183.
20. Maple PAC, Jones CS, Andrews NJ. Time resolved fluorometric immunoassay, using europium labelled antihuman IgG, for the detection of human tetanus antitoxin in serum. J Clin Pathol. 2001; 54(10):812-815.
21. Layton GT. A micro enzyme linked immunosorbent assay (ELISA) and radioimmunosorbent technique (RIST) for the detection of immunity to clinical tetanus. Med Lab Sci. 1980; 37:323-329.
22. CPMP/SWP/728/95. Replacement of animal studies by in vitro models. European Agency for the Evaluation of Medicinal Products; 1997.
23. Charton E. Reduction and replacement of animal test in the European Pharmacopoeia: recent developments for monographs on biological substances. Pharmeuropa. 1999; 11:197-199.
24. Plikaytis BD, et al. Comparisons of standard curvefitting methods to quantitate Neisseria meningitides group A polysaccharide antibody levels by enzyme linked immunosorbent assay. J Clin Microbiol. 1991; 29:1439-1446.
25. Plikaytis BD, et al. Program ELISA user’s manual. Atlanta: Center for Disease Control and Prevention; 1993.
26. Broughton PMG, et al. Guidelines for a user laboratory to evaluate and select a kit for its own use. Part 1: Quantitative test. European Committee for Clinical Laboratory Standards; 1986.
27. Ochoa R. et al. Principios y procedimientos para la validación de inmunoensayos cuantitativos empleados para evaluar la inmunogenicidad de vacunas. Vaccimonitor. 1999; 8(10):9-13.
28. WHO. Biologicals Substances. International Standards & Reference Reagents; 1991.
29. FDA. Minimum requirements: Tetanus toxoid. Public Health Service; 1953.
30. Wang AS. Detection of antibodies to tetanus toxoid: comparison of the direct haemagglutination method with a radioimmunoassay. J Clin Pathol. 1982; 35: 1138-1141.
31.Melville-Smith ME, et al. A comparison of enzymelinked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand. 1983; 11:137-144.